First in vivo evaluation of a potential SPECT brain radiotracer for the gonadotropin releasing hormone receptor

被引:0
作者
Fjellaksel R. [1 ,2 ,3 ,4 ]
Oteiza A. [1 ,4 ]
Martin-Armas M. [1 ,4 ]
Riss P.J. [5 ,6 ,7 ]
Hjelstuen O.K. [2 ]
Kuttner S. [1 ,4 ]
Hansen Jø.H. [3 ]
Sundset R. [1 ,4 ]
机构
[1] Medical Imaging Research Group, Department of Clinical Medicine, UiT, Arctic University of Norway, Tromsø
[2] Drug Transport and Delivery Research Group, Department of Pharmacy, UiT, Arctic University of Norway, Tromsø
[3] Organic Chemistry Research Group, Department of Chemistry, UiT, Arctic University of Norway, Tromsø
[4] PET Imaging Center, University Hospital of North Norway, Tromsø
[5] Department of Neuropsychiatry and Psychosomatic Medicine, Oslo University Hospital, Oslo
[6] Realomics SFI, Department of Chemistry, University of Oslo, Oslo
[7] Norsk Medisinsk Syklotronsenter AS, Postboks 4950, Nydalen, Oslo
关键词
Alpha-halogenation; GnRH; Gonadotropin; Radiotracer; SPECT;
D O I
10.1186/s13104-018-3924-2
中图分类号
学科分类号
摘要
Objectives: In vivo evaluations of a gonadotropin releasing hormone-receptor single photon emission computed tomography radiotracer for non-invasive detection of gonadotropin releasing homone-receptors in brain. Results: We have used a simple, robust and high-yielding procedure to radiolabel an alpha-halogenated bioactive compound with high radiochemical yield. Literature findings showed similar alpha-halogenated compounds suitable for in vivo evaluations. The compound was found to possess nano molar affinity for the gonadotropin releasing hormone-receptor in a competition dependent inhibition study. Furthermore, liquid chromatography-mass spectrometry analysis in saline, human and rat serum resulted in 46%, 52% and 44% stability after incubation for 1 h respectively. In addition, rat brain single photon emission computed tomography and biodistribution studies gave further insight into the nature of the compound as a radiotracer. © 2018 The Author(s).
引用
收藏
相关论文
共 21 条
[1]  
Cheung L.W.T., Wong A.S.T., Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues, FEBS J, 275, 22, pp. 5479-5495, (2008)
[2]  
Maggi R., Physiology of gonadotropin-releasing hormone (GnRH): Beyond the control of reproductive functions, MOJ Anat Physiol, 2, 5, pp. 150-154, (2016)
[3]  
Medicine I.O., Council N.R., Advancing Nuclear Medicine Through Innovation, (2007)
[4]  
Fjellaksel R., Dugalic D., Demissie T.B., Riss P.J., Hjelstuen O.K., Sundset R., Et al., An acylation-Finkelstein approach to radioiodination of bioactives: The role of amide group anchimeric assistance, J Phys Org Chem., 31, 7, (2018)
[5]  
Fjellaksel R., Sundset R., Riss P.J., Hansen J.H., Copper-mediated late-stage iodination and <sup>123</sup>I-labelling of triazole-benzimidazole bioactives, Synlett, 29, 11, pp. 1491-1495, (2018)
[6]  
Kamarainen E.-L., Kyllonen T., Airaksinen A., Lundkvist C., Yu M., Nagren K., Et al., Preparation of [<sup>18</sup>F]β-CFT-FP and [<sup>11</sup>C]β-CFT-FP, selective radioligands for visualisation of the dopamine transporter using positron emission tomography (PET), J Labelled Compd Radiopharm, 43, 12, pp. 1235-1244, (2000)
[7]  
Block D., Coenen H.H., Stocklin G., The N.C.A nucleophilic 18F-fluorination of 1,N-disubstituted alkanes as fluoroalkylation agents, J Labelled Compd Radiopharm, 24, 9, pp. 1029-1042, (1987)
[8]  
Fan L., Adams A.M., Polisar J.G., Ganem B., Studies on the chemistry and reactivity of α-substituted ketones in isonitrile-based multicomponent reactions, J Org Chem, 73, 24, pp. 9720-9726, (2008)
[9]  
Legros C., Matthey U., Grelak T., Pedragona-Moreau S., Hassler W., Yous S., Et al., New radioligands for describing the molecular pharmacology of MT1 and MT2 melatonin receptors, Int J Mol Sci, 14, 5, pp. 8948-8962, (2013)
[10]  
Legros C., Brasseur C., Delagrange P., Ducrot P., Nosjean O., Boutin J.A., Alternative radioligands for investigating the molecular pharmacology of melatonin receptors, J Pharmacol Exp Ther, 356, 3, pp. 681-692, (2016)